Julphar is one of the largest pharmaceutical manufacturer and distributors in the Middle East and North Africa (MENA), with a presence across five continents. Based in the Northern Emirate of Ras Al Khaimah, Julphar was established in 1980 under the visionary leadership of His Highness Sheikh Saqr Bin Mohammed Al Qasimi. With twelve state of the art and ISO certified manufacturing facilities located in the UAE, Julphar currently distributes 3,537 registered medical products internationally. The organizations’ mission is to offer high quality medicines at competitive prices, whilst also working towards positioning Ras Al Khaimah as a robust and growing market with a diversified economic base. Well positioned to meet tomorrow’s healthcare challenges, Julphar maintains a diverse product portfolio which target major therapeutic segments including endocrinology, anti-infective, cardiovascular and gastroenterology, over-the-counter, nephrology, dermatology, respiratory, metabolic and burn and wound management. Our commitment to quality has earned us ISO 9001 and ISO 14001 certifications. These international recognitions are a testament of the best practices that have been implemented not only for our manufacturing process, but also to ensure effective use of resources and waste reduction. In line with our objective to promote better diabetes management in the region, Julphar is now the only company in the Middle East to produce the raw material needed to make insulin through our division dedicated to Diabetes. Emerging markets are a key priority and in order to support our sustained growth in this segment, our subsidiary transportation company, Menacool, is intrinsically present across strategic locations to allow seamless distribution of our products to customers. With over 800 products in various dosage forms and more in the pipeline, Julphar is a stellar example of one of the UAE’s local businesses making an impact on the global stage. Julphar employs over 2800 personnel around the world and the company reported year-end sales of approximately AED 1.18 billion in 2012. For more information, please visit www.julphar.net
